288 related articles for article (PubMed ID: 15542433)
1. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells.
Bafico A; Liu G; Goldin L; Harris V; Aaronson SA
Cancer Cell; 2004 Nov; 6(5):497-506. PubMed ID: 15542433
[TBL] [Abstract][Full Text] [Related]
2. β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation.
Geyer FC; Lacroix-Triki M; Savage K; Arnedos M; Lambros MB; MacKay A; Natrajan R; Reis-Filho JS
Mod Pathol; 2011 Feb; 24(2):209-31. PubMed ID: 21076461
[TBL] [Abstract][Full Text] [Related]
3. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
4. The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis.
Knippschild U; Krüger M; Richter J; Xu P; García-Reyes B; Peifer C; Halekotte J; Bakulev V; Bischof J
Front Oncol; 2014; 4():96. PubMed ID: 24904820
[TBL] [Abstract][Full Text] [Related]
5. Cancer statistics, 2014.
Siegel R; Ma J; Zou Z; Jemal A
CA Cancer J Clin; 2014; 64(1):9-29. PubMed ID: 24399786
[TBL] [Abstract][Full Text] [Related]
6. Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis.
Moumen M; Chiche A; Decraene C; Petit V; Gandarillas A; Deugnier MA; Glukhova MA; Faraldo MM
Mol Cancer; 2013 Oct; 12(1):132. PubMed ID: 24171719
[TBL] [Abstract][Full Text] [Related]
7. Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties.
Bibian M; Rahaim RJ; Choi JY; Noguchi Y; Schürer S; Chen W; Nakanishi S; Licht K; Rosenberg LH; Li L; Feng Y; Cameron MD; Duckett DR; Cleveland JL; Roush WR
Bioorg Med Chem Lett; 2013 Aug; 23(15):4374-80. PubMed ID: 23787102
[TBL] [Abstract][Full Text] [Related]
8. A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.
Zhang X; Claerhout S; Prat A; Dobrolecki LE; Petrovic I; Lai Q; Landis MD; Wiechmann L; Schiff R; Giuliano M; Wong H; Fuqua SW; Contreras A; Gutierrez C; Huang J; Mao S; Pavlick AC; Froehlich AM; Wu MF; Tsimelzon A; Hilsenbeck SG; Chen ES; Zuloaga P; Shaw CA; Rimawi MF; Perou CM; Mills GB; Chang JC; Lewis MT
Cancer Res; 2013 Aug; 73(15):4885-97. PubMed ID: 23737486
[TBL] [Abstract][Full Text] [Related]
9. β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression.
Schade B; Lesurf R; Sanguin-Gendreau V; Bui T; Deblois G; O'Toole SA; Millar EK; Zardawi SJ; Lopez-Knowles E; Sutherland RL; Giguère V; Kahn M; Hallett M; Muller WJ
Cancer Res; 2013 Jul; 73(14):4474-87. PubMed ID: 23720052
[TBL] [Abstract][Full Text] [Related]
10. The planar cell polarity pathway drives pathogenesis of chronic lymphocytic leukemia by the regulation of B-lymphocyte migration.
Kaucká M; Plevová K; Pavlová S; Janovská P; Mishra A; Verner J; Procházková J; Krejcí P; Kotasková J; Ovesná P; Tichy B; Brychtová Y; Doubek M; Kozubík A; Mayer J; Pospísilová S; Bryja V
Cancer Res; 2013 Mar; 73(5):1491-501. PubMed ID: 23338609
[TBL] [Abstract][Full Text] [Related]
11. WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer.
Wend P; Runke S; Wend K; Anchondo B; Yesayan M; Jardon M; Hardie N; Loddenkemper C; Ulasov I; Lesniak MS; Wolsky R; Bentolila LA; Grant SG; Elashoff D; Lehr S; Latimer JJ; Bose S; Sattar H; Krum SA; Miranda-Carboni GA
EMBO Mol Med; 2013 Feb; 5(2):264-79. PubMed ID: 23307470
[TBL] [Abstract][Full Text] [Related]
12. Casein kinase I epsilon interacts with mitochondrial proteins for the growth and survival of human ovarian cancer cells.
Rodriguez N; Yang J; Hasselblatt K; Liu S; Zhou Y; Rauh-Hain JA; Ng SK; Choi PW; Fong WP; Agar NY; Welch WR; Berkowitz RS; Ng SW
EMBO Mol Med; 2012 Sep; 4(9):952-63. PubMed ID: 22707389
[TBL] [Abstract][Full Text] [Related]
13. Expression of dickkopf-1 and beta-catenin related to the prognosis of breast cancer patients with triple negative phenotype.
Xu WH; Liu ZB; Yang C; Qin W; Shao ZM
PLoS One; 2012; 7(5):e37624. PubMed ID: 22649545
[TBL] [Abstract][Full Text] [Related]
14. Wnt signaling in cancer.
Polakis P
Cold Spring Harb Perspect Biol; 2012 May; 4(5):. PubMed ID: 22438566
[TBL] [Abstract][Full Text] [Related]
15. Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo.
Hirner H; Günes C; Bischof J; Wolff S; Grothey A; Kühl M; Oswald F; Wegwitz F; Bösl MR; Trauzold A; Henne-Bruns D; Peifer C; Leithäuser F; Deppert W; Knippschild U
PLoS One; 2012; 7(1):e29709. PubMed ID: 22235331
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapies for breast cancer.
Higgins MJ; Baselga J
J Clin Invest; 2011 Oct; 121(10):3797-803. PubMed ID: 21965336
[TBL] [Abstract][Full Text] [Related]
17. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.
Mermel CH; Schumacher SE; Hill B; Meyerson ML; Beroukhim R; Getz G
Genome Biol; 2011; 12(4):R41. PubMed ID: 21527027
[TBL] [Abstract][Full Text] [Related]
18. IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation.
Cheong JK; Nguyen TH; Wang H; Tan P; Voorhoeve PM; Lee SH; Virshup DM
Oncogene; 2011 Jun; 30(22):2558-69. PubMed ID: 21258417
[TBL] [Abstract][Full Text] [Related]
19. Notch signaling pathway as a therapeutic target in breast cancer.
Al-Hussaini H; Subramanyam D; Reedijk M; Sridhar SS
Mol Cancer Ther; 2011 Jan; 10(1):9-15. PubMed ID: 20971825
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration.
Foldynová-Trantírková S; Sekyrová P; Tmejová K; Brumovská E; Bernatík O; Blankenfeldt W; Krejcí P; Kozubík A; Dolezal T; Trantírek L; Bryja V
Breast Cancer Res; 2010; 12(3):R30. PubMed ID: 20507565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
